Connect your AI

Elevance Health ELV Stock Issuance Proceeds

Stock Issuance Proceeds at other companies

CVS HealthCVS

$103M-28.5%

UnitedHealth GroupUNH

$231M-35.8%

CenteneCNC

$10M0.0%

Oscar HealthOSCR

$1.14M-80.1%

CignaCI

$57M-17.4%

Alignment HealthcareALHC

$2.17M+950%

Other financials

Income statement

Revenue$50.2B+2.6%

Gross profit$44.7B+1.8%

Net income$1.8B-19.2%

EPS (diluted)$8.00-16.8%

Balance sheet

Cash & equivalents$9.7B+28.8%

Total debt$31.5B+11.0%

Total equity$43.9B+3.3%

Total assets$125.83B+5.1%

Cash flow

Operating cash flow$4.3B+326%

CapEx$235.0M+19.9%

Free cash flow$4.1B+399%

Valuation

Market cap$83.98B+7.6%

Enterprise value$105.82B+8.0%

P/E16×+1.5×

P/S0.4×0.0×

Profitability

Gross margin89.2%+0.6pp

Net margin2.6%-0.6pp

FCF margin3.3%+1.3pp

Returns & leverage

Return on equity12.1%-2.1pp

Debt / equity0.7×+0.1×

Current ratio1.5×0.0×

Where this comes from

Reported directly by Elevance Health in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromStockOptionsExercised.

The official record: Elevance Health’s 10-Q, filed April 22, 2026, on SEC EDGAR. View the filing →

Ask your AI about Elevance Health's stock issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Elevance Health's stock issuance proceeds?: Elevance Health (ELV) reported stock issuance proceeds of $37M in Q1 2026.
How has Elevance Health's stock issuance proceeds changed year-over-year?: Elevance Health's stock issuance proceeds increased by 60.9% year-over-year, from $23M to $37M.
What is the long-term trend for Elevance Health's stock issuance proceeds?: Over 2 years (2021 to 2023), Elevance Health's stock issuance proceeds has grown at a -13.5% compound annual growth rate (CAGR), from $203M to $152M.
What does stock issuance proceeds mean?: Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.